AI
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
The Australian government-approved therapy has shown "remarkable" results after 18 sessions.
The AKF and Ubie will fine-tune the digital health company's AI-enabled symptom checker to help accelerate kidney disease diagnosis.
Ashok Chennuru, global chief data and insights officer at Elevance Health, and Oron Afek, CEO of Vim, discuss scaling artificial intelligence to accelerate workflows, enhance patient care and unlock personalized medicine.
HIMSS24
Joe O'Brien, head of sales, digital health at LG Electronics, says the company plans to use AI tools in smart hospital rooms to provide better patient experiences by supplementing, not replacing, in-person care.
Adjunct faculty at Stanford Health Care and CMO and cofounder of Atropos Health, Saurabh Gombar, discusses a study analyzing five LLMs and their accuracy in producing actionable and reliable evidence for healthcare-related questions.
Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.
HIMSS24
Marilee Benson, president and cofounder of Zen Healthcare IT, talks about how the company's interoperability product enables AI tools to access healthcare data needed for use cases such as identifying patients for clinical trials.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.
HIMSS24
Zsolt Kulcsar, Lee Health's systems medical director of virtual health, discusses his team's upcoming AI chatbot, which will contact patients with unusual RPM biometric readings to determine if alerting a nurse is necessary.